SIRNA TARGETING AND REGULATING PCSK9 GENE EXPRESSION AND USE THEREOF
案件概要
出願人
Hangzhou Tianlong Pharmaceutical Co., Ltd.
発明者
Gengshen SONG; Zeao HUANG; Shuo YANG; Zhikang TIAN; Yucheng WU; Peng YAO; Xiaowen YU; Dawei HUANG; Xue PANG; Fang LIN
IPC分類
CPC分類
The present disclosure relates to siRNAs that target and regulate PCSK9 gene expression and use thereof. Experimental results show that some alternately modified and specific template-modified oligonucleotide sequences can significantly inhibit PCSK9 expression and can be used to develop drugs to treat PCSK9-related diseases.
原文（中国語）
The present disclosure relates to siRNAs that target and regulate PCSK9 gene expression and use thereof. Experimental results show that some alternately modified and specific template-modified oligonucleotide sequences can significantly inhibit PCSK9 expression and can be used to develop drugs to treat PCSK9-related diseases.
外部リソース